CAS 2756809-34-2

Heptanamide, N-hydroxy-7-[(8-oxo-8H-phthalazino[1,2-b]quinazolin-5-yl)amino]-

Description:

Heptanamide, N-hydroxy-7-[(8-oxo-8H-phthalazino[1,2-b]quinazolin-5-yl)amino]- is a synthetic organic compound characterized by its complex structure, which includes a heptanamide backbone and a phthalazinone moiety. This compound features a hydroxylamine functional group, which can enhance its reactivity and potential biological activity. The presence of the quinazoline and phthalazine rings suggests that it may exhibit interesting pharmacological properties, possibly acting as an inhibitor or modulator in various biochemical pathways. The molecular structure indicates potential for hydrogen bonding due to the hydroxyl group, which may influence its solubility and interaction with biological targets. Additionally, the compound's unique arrangement of functional groups may contribute to its specificity and efficacy in medicinal chemistry applications. As with many synthetic compounds, understanding its stability, reactivity, and potential toxicity is crucial for evaluating its suitability for research or therapeutic use. Further studies would be necessary to elucidate its complete profile and potential applications in drug development.

Formula: C₂₂H₂₃N₅O₃

Synonyms:

• HDAC-IN-30
• Heptanamide, N-hydroxy-7-[(8-oxo-8H-phthalazino[1,2-b]quinazolin-5-yl)amino]-

HDAC-IN-30

CAS: 2756809-34-2

HDAC-IN-30 is a potent HDAC inhibitor targeting HDAC1, 2, 3, 6, and 8 with strong antitumor efficacy.

Formula: C₂₂H₂₃N₅O₃

Color and Shape: Solid

Molecular weight: 405.45

Ref: TM-T62006